Official UK procurement notice
NP39823 Gastro Intestinal, Endocrine, Nutrition & Blood Medicine
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") (NHS & healthcare)
What is being bought14 lots · detail below
Published requirement descriptionSupply of Gastro Intestinal, Endocrine, Nutrition & Blood Medicines to NHS Scotland.
CPV: Pharmaceutical products
How this framework works
From the published notice- Bids received
- 46 bids on the busiest of 13 lots · 53 suppliers appointed
Lots and requirements (14)Procurement structure
14 lots · all with a published value · same evaluation weights on every lotLot #1Desferrioxamine InjectionsAwardedRenewalPublished value£279,730
Supply of Desferrioxamine Injections to NHS Scotland. The Authority has awarded this framework as a single supplier framework per lot to one (1) Framework Participant.
Lot #2Dexamethasone InjectionAwardedRenewalPublished value£465,823
Supply of Dexamethasone Injections to NHS Scotland. The Authority has awarded this framework as a unranked multi-supplier framework per line to a maximum of five (5) Framework Participants.
Lot #3Macrogol Oral Powder & SolutionsAwardedRenewalPublished value£3,977,182
Supply of Macrogol Oral Powder & Solutions to NHS Scotland. The Authority has awarded this framework as a unranked multi-supplier framework per line to a maximum of three (3) Framework Participants.
Lot #4MesalazineAwardedRenewalPublished value£255,986
Supply of Mesalazine to NHS Scotland. The Authority has awarded this framework as a unranked multi-supplier framework per line to a maximum of five (5) Framework Participants.
Lot #5Magnesium sulfateAwardedRenewalPublished value£376,615
Supply of Magnesium sulfate to NHS Scotland. The Authority has awarded this framework as a unranked multi-supplier framework per line to a maximum of five (5) Framework Participants.
Lot #6Colecalciferol & Calcium Carbonate tabletsAwardedRenewalPublished value£970,873
Supply of Colecalciferol & Calcium Carbonate tablets to NHS Scotland. The Authority has awarded this framework as a unranked multi-supplier framework per line to a maximum of eight (8) Framework Participants.
Lot #7BudesonideAwardedRenewalPublished value£382,449
Supply of Budesonide to NHS Scotland. The Authority has awarded this framework as a unranked multi-supplier framework per line to a maximum of three (3) Framework Participants.
Lot #8Vitamin with minerals and trace elementsRenewalPublished value£17,331
Supply of Vitamin with minerals and trace elements to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework per line to a maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Lot #9PancreatinAwardedRenewalPublished value£619,311
Supply of Pancreatin to NHS Scotland. The Authority has awarded this framework as a unranked multi-supplier framework per line to a maximum of two (2) Framework Participants.
Lot #10All Other PresentationsAwardedRenewalPublished value£32,037,618
Supply of all other presentations to NHS Scotland. The Authority has awarded this framework as a single supplier framework per line to one (1) Framework Participant.
Lot #11TrientineAwardedRenewalPublished value£1,419,890
Supply of Trientine to NHS Scotland. The Authority has awarded this framework as a single supplier framework per line to one (1) Framework Participant.
Lot #12Teriparatide InjectionsAwardedRenewalPublished value£1,416,494
Supply of Teriparatide Injections to NHS Scotland. The Authority has awarded this framework as a unranked multi-supplier framework per line to a maximum of five (5) Framework Participants.
Lot #13Tolvaptan TabletsAwardedRenewalPublished value£2,930,445
Supply of Tolvaptan Tablets to NHS Scotland. The Authority has awarded this framework as a single supplier framework per line to one (1) Framework Participant.
Lot #14Sapropterin & Deferasriox TabletsAwardedRenewalPublished value£267,776
Supply of Sapropterin & Deferasriox Tablets to NHS Scotland. The Authority has awarded this framework as a single supplier framework per line to one (1) Framework Participant.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (2)
- Logistics: 5%
- price: 95%
Published award criteria (2)
- Logistics: 5
- Price: 95
- Suitability
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.
- Technical & professional ability
(a)Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender.
(b)Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
(c)All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.
(d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.
Minimum: (a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Te…
- Price carries 95 of 100 points: a 10% discount moves about 9.5 points. This one is won on the number: sharpen the price before polishing the prose.
- “NP39823 Gastro Intestinal, Endocrine, Nutrition & Blood Medicine” is a framework: the contest is a place on its panel, not a single contract.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 9 Mar 2023, 09:07 GMT
- Last source update
- 8 Sept 2023, 08:42 BST
- Award evaluation window
- 11 Apr 2023 – …
- FTS notice number
2023/S 000-026558- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-03b0c5Find a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Review procedure
Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:
An economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.
The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.
Publisher note: The estimated value(s) referred to in Section II.1.5 and within all Lots cover(s) the twenty-four (24) month contract duration and the twenty-four (24) month extension period of the framework agreement. The Goods within this procurement were separated and advertised as fourteen (14) categories, each of which was identified as a “Lot”. Out of the fourteen (14) Lots, thirteen (13) Lots have been awarded. For details of the Lot not awarded, or details of individual lines awarded within a Lot contact the named person at head of notice. (SC Ref:740774)
How it was run
Official notice- Appointment period ends
- 11 Apr 2023, 12:00 BST
- Submission channel
- {"electronicSubmission"}
- Accepted languages
- en
- Bids opened
- 11 Apr 2023, 12:00 BST
Timeline
11 Apr 2023 → 8 Sept 2023 · 3 dates- Admission / appointment period endsperiod end, not a bid countdown11 Apr 2023, 12:00 BST
- Bids opened11 Apr 2023, 12:00 BST
- Notice published8 Sept 2023, 08:42 BST
Notice history
1 event · 2 releases on Find a Tender- Status changed to complete8 Sept 2023, 08:42 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast13 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Desferrioxamine Injections
- Signed
- 21 Jun 2023
- Value
- £357,817
- Status
- active
Teriparatide Injections
- Signed
- 21 Jun 2023
- Value
- £1,415,369
- Status
- active
Tolvaptan Tablets
- Signed
- 21 Jun 2023
- Value
- £2,090,164
- Status
- active
Sapropterin & Deferasriox Tablets
- Signed
- 21 Jun 2023
- Value
- £145,484
- Status
- active
Dexamethasone Injection
- Signed
- 21 Jun 2023
- Value
- £494,600
- Status
- active
Macrogol Oral Powder & Solutions
- Signed
- 21 Jun 2023
- Value
- £4,570,919
- Status
- active
Colecalciferol & Calcium Carbonate tablets
- Signed
- 21 Jun 2023
- Value
- £384,016
- Status
- active
Magnesium sulfate
- Signed
- 21 Jun 2023
- Value
- £270,449
- Status
- active
Mesalazine
- Signed
- 21 Jun 2023
- Value
- £232,335
- Status
- active
Budesonide
- Signed
- 21 Jun 2023
- Value
- £220,973
- Status
- active
Pancreatin
- Signed
- 21 Jun 2023
- Value
- £697,314
- Status
- active
All Other Presentations
- Signed
- 21 Jun 2023
- Value
- £23,844,830
- Status
- active
Trientine
- Signed
- 21 Jun 2023
- Value
- £1,419,890
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · Desferrioxamine Injections | 1bids · 1 electronic · 1 from abroad | 0 | — | — |
| 2 · Dexamethasone Injection | 7bids · 7 electronic · 7 from abroad | 5 | — | — |
| 3 · Macrogol Oral Powder & Solutions | 3bids · 3 electronic · 3 from abroad | 2 | — | — |
| 4 · Mesalazine | 7bids · 7 electronic · 7 from abroad | 2 | — | — |
| 5 · Magnesium sulfate | 5bids · 5 electronic · 5 from abroad | 4 | — | — |
| 6 · Colecalciferol & Calcium Carbonate tablets | 8bids · 8 electronic · 8 from abroad | 6 | — | — |
| 7 · Budesonide | 3bids · 3 electronic · 3 from abroad | 2 | — | — |
| 9 · Pancreatin | 2bids · 2 electronic · 2 from abroad | 2 | — | — |
| 10 · All Other Presentations | 46bids · 46 electronic · 46 from abroad | 35 | — | — |
| 11 · Trientine | 2bids · 2 electronic · 2 from abroad | 2 | — | — |
| 12 · Teriparatide Injections | 5bids · 5 electronic · 5 from abroad | 3 | — | — |
| 13 · Tolvaptan Tablets | 1bids · 1 electronic · 1 from abroad | 1 | — | — |
| 14 · Sapropterin & Deferasriox Tablets | 7bids · 7 electronic · 7 from abroad | 2 | — | — |
Contracting authority & participating public bodies
Framework contractors & participating bidders
53 commercial parties on the notice · 50 awardedThe first 50 of 53 commercial parties (by name); the JSON mirror lists them all.
- AbbVie LtdFramework contractor
- AccordFramework contractor
- Aspire Pharma LtdFramework contractor
- Bristol Laboratories LtdFramework contractor
- Brown and BurkFramework contractor
- CST Pharma LtdFramework contractor
- Chiesi LimitedFramework contractor
- Colonis Pharma LtdFramework contractor
- Consilient Health LtdFramework contractor
- Crescent Pharma LimitedFramework contractor
Show 40 more suppliers
- Day Lewis Medical LtdFramework contractor
- Dr Falk Pharma UK LtdFramework contractor
- Dr. Reddy's LaboratoriesFramework contractor
- Eli Lilly & Company LimitedFramework contractor
- Ennogen Healthcare LtdFramework contractor
- Eurocept InternationalFramework contractor
- Ferring Pharmaceuticals LimitedFramework contractor
- Focus Pharmaceuticals LtdFramework contractor
- Galen LtdFramework contractor
- Gedeon RichterFramework contractor
- GlaxoSmithKlineFramework contractor
- Glenmark Pharmaceuticals Europe LtdFramework contractor
- Intrapharm Laboratories LtdFramework contractor
- Kent Pharmaceuticals LtdFramework contractor
- Kyowa KirinFramework contractor
- MSN LabsFramework contractor
- Martindale PharmaFramework contractor
- Medreich PLCFramework contractor
- Mercury Pharma GroupFramework contractor
- Morningside Pharmaceuticals LimitedFramework contractor
- Norgine Pharmaceuticals LimitedFramework contractor
- Orphalan LtdFramework contractor
- P M Pharma LtdFramework contractor
- Panpharma UK LtdFramework contractor
- Pfizer LimitedFramework contractor
- RPH Pharma LtdFramework contractor
- Ranbaxy (UK) LtdFramework contractor
- Reckitt BenckiserFramework contractor
- Rosemont PharmaceuticalsFramework contractor
- Sandoz LtdFramework contractor
- Selective Supplies LtdFramework contractor
- Stirling Anglian PharmaceuticalsFramework contractor
- Synchrony Pharma LtdFramework contractor
- Takeda UK LimitedFramework contractor
- Teva UK LimitedFramework contractor
- Thornton & Ross LtdFramework contractor
- Tillotts Pharma UK LtdFramework contractor
- Typharm LtdFramework contractor
- Univar Solutions B.VFramework contractor
- Viatris UK Healthcare LtdFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.